Biotech experts- OREX, VVUS
This is for anyone who is a biotech expert or trades biotech companies. There are a lot of call options for VVUS in Sept.
I am familiar with Vivus's drug Qnexa, but not Orexigen's. One of Qnexa's ingredients is already being utilized phentermine (Adipex-P). Not familiar with Orexigen. Anyways, just curious on ppl's take on these anti-obesity drugs looming FDA approval. I normally do not trade biotech, but these drugs being that obesity is a chronic issue throughout the world have potential if approved.
My hang up is that if Qnexa (Vivus's drug) gets denied, it will be for side effects and risks vs. effectiveness.